Suppr超能文献

免疫耐受。第3组固有淋巴细胞介导共生菌特异性CD4⁺T细胞的肠道选择。

Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.

作者信息

Hepworth Matthew R, Fung Thomas C, Masur Samuel H, Kelsen Judith R, McConnell Fiona M, Dubrot Juan, Withers David R, Hugues Stephanie, Farrar Michael A, Reith Walter, Eberl Gérard, Baldassano Robert N, Laufer Terri M, Elson Charles O, Sonnenberg Gregory F

机构信息

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Gastroenterology Division, and Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY, USA.

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Gastroenterology Division, and Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY, USA. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Science. 2015 May 29;348(6238):1031-5. doi: 10.1126/science.aaa4812. Epub 2015 Apr 23.

Abstract

Inflammatory CD4(+) T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII(+) ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4(+) T cells in the intestine and suggest that this process is dysregulated in human IBD.

摘要

炎症性CD4(+) T细胞对自身或共生菌的反应分别是自身免疫性疾病和炎症性肠病(IBD)发病机制的基础。虽然胸腺中自身特异性T细胞的选择限制了对哺乳动物组织抗原的反应,但控制共生菌特异性T细胞选择的机制仍知之甚少。在这里,我们证明3型固有淋巴细胞(ILC3)主要组织相容性复合体II类(MHCII)的内在表达与胸腺上皮细胞的调节方式相似,并且MHCII(+) ILC3s直接诱导活化的共生菌特异性T细胞死亡。此外,儿科IBD患者结肠ILC3s上的MHCII减少。这些结果共同定义了肠道中共生菌特异性CD4(+) T细胞的选择途径,并表明该过程在人类IBD中失调。

相似文献

3
Copycat innate lymphoid cells dampen gut inflammation.复制型先天淋巴细胞可抑制肠道炎症。
Cell Res. 2015 Sep;25(9):991-2. doi: 10.1038/cr.2015.79. Epub 2015 Jun 26.
4
Escaping Negative Selection: ILC You in the Gut.逃避阴性选择:肠道中的固有淋巴细胞
Immunity. 2015 Jul 21;43(1):12-4. doi: 10.1016/j.immuni.2015.07.006.

引用本文的文献

本文引用的文献

2
Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses.活化的3型天然淋巴细胞促进T细胞介导的免疫反应。
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12835-40. doi: 10.1073/pnas.1406908111. Epub 2014 Aug 18.
5
T-cell selection and intestinal homeostasis.T细胞选择与肠道内稳态。
Immunol Rev. 2014 May;259(1):60-74. doi: 10.1111/imr.12171.
7
Role of the microbiota in immunity and inflammation.微生物群在免疫和炎症中的作用。
Cell. 2014 Mar 27;157(1):121-41. doi: 10.1016/j.cell.2014.03.011.
9
Controlling the frontier: regulatory T-cells and intestinal homeostasis.控制前沿:调节性 T 细胞与肠道内稳态。
Semin Immunol. 2013 Nov 30;25(5):352-7. doi: 10.1016/j.smim.2013.09.002. Epub 2013 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验